http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103446094-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56f3f77865ceaebe064e8d9fb1816c5f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
| filingDate | 2013-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ea1645519112429a548752301ac8a82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_746a5e17338c95b5c937c510da5f80cd |
| publicationDate | 2013-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103446094-A |
| titleOfInvention | Application of Incarviatone A in anti-respiratory syncytial virus drug |
| abstract | The invention discloses application of Incarviatone A in preparation of an anti-respiratory syncytial virus drug. An experiment proves that the Incarviatone A has remarkable inhibiting effect on respiratory syncytial virus (RSV). An experimental basis is provided for clinic application of the Incarviatone A for treating the RSV infectious diseases, a certain guiding significance is provided for development of the anti-RSV drug, and the application of the Incarviatone A has important reference value. |
| priorityDate | 2013-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11105 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451743945 |
Total number of triples: 14.